Skip to main content
Loading market data...
Last price 32.92 USD Change: Up +0.26 Percent change: Up +0.81%

Source: Yahoo Finance (opens in a new tab) Observed · 1 day ago Quotes may be delayed

Expense ratio
0.50%
Prospectus 30 Jun 2026
Net assets
$90.9M
As of 31 May 2026
Holdings
165
As of 31 May 2026
12-month distribution yield
1.34%
Quarterly
Asset class
Equity
From holdings

GMO US Value ETF (GMOV) is an exchange-traded fund listed on NYSE Arca in the United States, issued by GMO. Its category is Equity · US (equity). Its last price was US$32.92 on 20 Oct 2026. Its expense ratio is 0.5% a year, from its prospectus dated 30 Jun 2026. It reported net assets of US$90.92 million as of 31 May 2026. Its latest holdings report lists 165 holdings as of 31 May 2026. Over the last 12 months it paid distributions of US$0.44 a unit, a 12-month distribution yield of 1.34%, paid quarterly.

General information only: nothing on TakeProfits takes into account your objectives, financial situation or needs, and it isn't personal financial advice or a recommendation to buy or sell anything. Consider whether it suits you and get advice from a licensed adviser before acting. Market data may be delayed and comes from third-party sources.

Fees

Total annual operating expenses (gross)
0.50%
Net, after fee waivers or reimbursements
No waiver stated
Management fee
0.50%
Prospectus date
30 Jun 2026
Filed with the SEC
30 Jun 2026

Size and reporting

Net assets
$90,915,029
Total assets
$90,952,301
Holdings as of
31 May 2026
Report made public
29 Jul 2026 (59 days after the month end)

Net assets are for the whole fund series, which for some funds (Vanguard's, for example) also includes mutual fund share classes.

Top holdings

Largest 25 of 165 positions, as of 31 May 2026. Weight is the percent of net assets the fund reported.

GMOV top holdings as of 31 May 2026
# Holding Identifier Weight Value (USD) Type Country Currency
1 Meta Platforms Inc US30303M1027 5.18% $4.7M Equity (common) United States USD
2 Alphabet Inc US02079K3059 3.89% $3.5M Equity (common) United States USD
3 QUALCOMM Inc US7475251036 3.36% $3.1M Equity (common) United States USD
4 Merck & Co Inc US58933Y1055 2.73% $2.5M Equity (common) United States USD
5 Exxon Mobil Corp US30231G1022 2.58% $2.3M Equity (common) United States USD
6 Verizon Communications Inc US92343V1044 2.37% $2.2M Equity (common) United States USD
7 Bank of America Corp US0605051046 2.19% $2.0M Equity (common) United States USD
8 Pfizer Inc US7170811035 2.10% $1.9M Equity (common) United States USD
9 UnitedHealth Group Inc US91324P1021 2.02% $1.8M Equity (common) United States USD
10 Johnson & Johnson US4781601046 1.98% $1.8M Equity (common) United States USD
11 Comcast Corp US20030N1019 1.89% $1.7M Equity (common) United States USD
12 JPMorgan Chase & Co US46625H1005 1.70% $1.5M Equity (common) United States USD
13 Bristol-Myers Squibb Co US1101221083 1.66% $1.5M Equity (common) United States USD
14 AT&T Inc US00206R1023 1.63% $1.5M Equity (common) United States USD
15 Procter & Gamble Co/The US7427181091 1.54% $1.4M Equity (common) United States USD
16 Cigna Group/The US1255231003 1.53% $1.4M Equity (common) United States USD
17 Target Corp US87612E1064 1.50% $1.4M Equity (common) United States USD
18 United Parcel Service Inc US9113121068 1.47% $1.3M Equity (common) United States USD
19 Citigroup Inc US1729674242 1.33% $1.2M Equity (common) United States USD
20 Progressive Corp/The US7433151039 1.30% $1.2M Equity (common) United States USD
21 EOG Resources Inc US26875P1012 1.28% $1.2M Equity (common) United States USD
22 International Business Machines Corp US4592001014 1.24% $1.1M Equity (common) United States USD
23 CVS Health Corp US1266501006 1.21% $1.1M Equity (common) United States USD
24 Regeneron Pharmaceuticals Inc US75886F1075 1.19% $1.1M Equity (common) United States USD
25 Allstate Corp/The US0200021014 1.16% $1.1M Equity (common) United States USD

Breakdowns

Sums of reported weights over every position in the report. Totals can differ from 100% because of derivatives, borrowing and cash.

Asset type

Asset type by weight
TypeWeightBar
Equity (common) 98.78%
Short-term investment vehicles (cash funds) 1.09%

Country

Country by weight
CountryWeightBar
United States 97.82%
Bermuda 0.72%
Switzerland 0.68%
Jersey 0.26%
Netherlands 0.20%
Ireland 0.19%

Currency exposure

Currency exposure by weight
CurrencyWeightBar
US dollar (USD) 99.87%

Sector

Sector weights for holdings matched to listed stocks
SectorWeightBar
Finance 20.17%
Technology 19.35%
Health Care 14.92%
Consumer Discretionary 14.81%
Industrials 6.78%
Telecommunications 6.56%
Consumer Staples 4.83%
Energy 4.67%
Real Estate 0.41%
Utilities 0.25%
Basic Materials 0.23%

Source: SEC Form N-PORT (opens in a new tab) Holdings as of

Distributions

Paid in the last 12 months
$0.4410
3 payments per unit
12-month yield
1.34%
Distributions only, not total return
Frequency
Quarterly
From the gaps between ex-dates
Latest ex-date
30 Jun 2026

12-month yield = distributions per unit with an ex-date in the last 12 months ($0.4410) ÷ latest price ($32.92) × 100 = 1.34%. It looks back, so it is not a forecast; special distributions in the window are included.

Why a distribution yield is not the fund's return: yield vs total return

Distribution history table (7 payments)
GMOV distributions per unit by ex-date
Ex-dateAmount per unit
30 Jun 2026$0.1280
31 Mar 2026$0.1690
30 Dec 2025$0.1440
30 Sep 2025$0.1500
1 Jul 2025$0.1470
31 Mar 2025$0.1040
30 Dec 2024$0.0730

Filings and sources

Compare with

Largest funds in the same category:

Up to four symbols separated by commas. ASX funds end in .AX, for example IVV.AX.

How ETF overlap is measured, with a worked example

IMPORTANT FINANCIAL DISCLAIMER: The information provided on this platform is for educational and informational purposes only and should not be construed as investment advice. All investments involve risk, including potential loss of principal. Past performance does not guarantee future results. Take Profits is not a registered investment advisor and does not provide personalized investment advice. Users should conduct their own research and consult with qualified financial professionals before making investment decisions. Market data may be delayed and is provided by third-party sources.

Catalyst evidence

Loading…

Loading evidence…

Supporting sources

    Skip to main content

    All resources and tools

    Market ticker

    Markets

    Research

    Tools

    My investments

    Account

    Region and currency

    Colour theme